JP2012521966A5 - - Google Patents

Download PDF

Info

Publication number
JP2012521966A5
JP2012521966A5 JP2011553339A JP2011553339A JP2012521966A5 JP 2012521966 A5 JP2012521966 A5 JP 2012521966A5 JP 2011553339 A JP2011553339 A JP 2011553339A JP 2011553339 A JP2011553339 A JP 2011553339A JP 2012521966 A5 JP2012521966 A5 JP 2012521966A5
Authority
JP
Japan
Prior art keywords
pain
urinary incontinence
epilepsy
mania
migraine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011553339A
Other languages
English (en)
Japanese (ja)
Other versions
JP5727945B2 (ja
JP2012521966A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/001449 external-priority patent/WO2010102779A1/de
Publication of JP2012521966A publication Critical patent/JP2012521966A/ja
Publication of JP2012521966A5 publication Critical patent/JP2012521966A5/ja
Application granted granted Critical
Publication of JP5727945B2 publication Critical patent/JP5727945B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011553339A 2009-03-10 2010-03-09 Kcnq2/3モジュレータとしての置換された3−アミノ−2−メルカプトキノリン Expired - Fee Related JP5727945B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09003431.5 2009-03-10
EP09003431 2009-03-10
PCT/EP2010/001449 WO2010102779A1 (de) 2009-03-10 2010-03-09 Substituierte 3-amino-2-mercaptochinoline als kcnq2/3 modulatoren

Publications (3)

Publication Number Publication Date
JP2012521966A JP2012521966A (ja) 2012-09-20
JP2012521966A5 true JP2012521966A5 (enExample) 2014-10-16
JP5727945B2 JP5727945B2 (ja) 2015-06-03

Family

ID=40591941

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011553339A Expired - Fee Related JP5727945B2 (ja) 2009-03-10 2010-03-09 Kcnq2/3モジュレータとしての置換された3−アミノ−2−メルカプトキノリン

Country Status (22)

Country Link
US (1) US8207342B2 (enExample)
EP (1) EP2406228B1 (enExample)
JP (1) JP5727945B2 (enExample)
KR (1) KR20110130461A (enExample)
CN (1) CN102341374A (enExample)
AR (1) AR075730A1 (enExample)
AU (1) AU2010223556B2 (enExample)
BR (1) BRPI1009519A2 (enExample)
CA (1) CA2754943A1 (enExample)
CL (1) CL2011002160A1 (enExample)
CO (1) CO6410291A2 (enExample)
EC (1) ECSP11011346A (enExample)
ES (1) ES2436365T3 (enExample)
IL (1) IL214944A0 (enExample)
MX (1) MX2011009338A (enExample)
NZ (1) NZ595569A (enExample)
PE (1) PE20120535A1 (enExample)
PL (1) PL2406228T3 (enExample)
RU (1) RU2011140701A (enExample)
TW (1) TWI504395B (enExample)
WO (1) WO2010102779A1 (enExample)
ZA (1) ZA201107370B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1009428A2 (pt) * 2009-03-10 2016-03-01 Gruenenthal Gmbh 3-aminoisoxazolopiridina substituída como moduladores de kcnq2/3
TW201038565A (en) 2009-03-12 2010-11-01 Gruenenthal Gmbh Substituted 2-mercapto-3-aminopyridines as KCNQ2/3 modulators
TWI461197B (zh) 2009-03-12 2014-11-21 2-mercaptoquinoline-3-carboxamide as a KCNQ2 / 3 modifier
TWI475020B (zh) 2009-03-12 2015-03-01 The substituted nicotine amide as a KCNQ2 / 3 modifier
RU2595894C2 (ru) 2010-08-27 2016-08-27 Грюненталь Гмбх Замещенные 2-окси-хинолин-3-карбоксамиды в качестве модуляторов kcnq2/3
TW201211007A (en) 2010-08-27 2012-03-16 Gruenenthal Gmbh Substituted 2-amino-quinoline-3-carboxamides as KCNQ2/3 modulators
HUE024870T2 (en) 2010-08-27 2016-02-29 Gruenenthal Gmbh Substituted 2-oxo and 2-thioxo-dihydroquinoline-3-carboxamides as modulators of KCNQ2 / 3
MX2013002295A (es) 2010-09-01 2013-05-09 Gruenenthal Gmbh 1-oxo-dihidroisoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
DE102018212006B3 (de) * 2018-07-18 2019-10-31 Universität Greifswald Thioether als Modulatoren von Kv7.2/Kv7.3-Kanälen

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2706977A1 (de) 1977-02-18 1978-08-24 Hoechst Ag Benzoesaeuren und deren derivate sowie verfahren zu ihrer herstellung
FR2532939A1 (fr) 1982-09-13 1984-03-16 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation, leur application comme medicament, les compositions les renfermant et les nouveaux intermediaires obtenus
DE4032147A1 (de) 1990-10-10 1992-04-16 Bayer Ag Verwendung von substituierten 2-mercaptonicotinsaeurederivaten zur bekaempfung von endoparasiten, neue substituierte 2-mercaptonicotinsaeurederivate und verfahren zu ihrer herstellung
US5583147A (en) * 1994-03-23 1996-12-10 The Dupont Merck Pharmaceutical Company Amides for the treatment of atherosclerosis
EP0716077A1 (de) 1994-12-08 1996-06-12 Ciba-Geigy Ag Aromatisch substituierte Omega-Aminoalkansäureamide und Alkansäurediamide und ihre Verwendung als Renininhibitoren
WO1996026925A1 (en) 1995-03-01 1996-09-06 Banyu Pharmaceutical Co., Ltd. Arylthioacetamide derivatives
CA2301549A1 (en) * 1997-08-28 1999-03-04 Piyasena Hewawasam 4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
DE19738616A1 (de) 1997-09-04 1999-03-11 Clariant Gmbh 4-Hydroxychinolin-3-carbonsäure-Derivate als Lichtschutzmittel
WO2000042026A1 (en) 1999-01-15 2000-07-20 Novo Nordisk A/S Non-peptide glp-1 agonists
EP1208085B1 (en) 1999-08-04 2007-12-05 Icagen, Inc. Benzanilides as potassium channel openers
JP2003506388A (ja) 1999-08-04 2003-02-18 アイカゲン インコーポレイテッド 疼痛および不安症を処置または予防するための方法
JP2005507853A (ja) 2001-02-20 2005-03-24 ブリストル−マイヤーズ スクイブ カンパニー Kcnqカリウムチャンネルモジュレーター並びに片頭痛および機構的に関連する疾患の治療におけるそれらの使用
EP1361879A1 (en) 2001-02-20 2003-11-19 Bristol-Myers Squibb Company 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators
US6593349B2 (en) 2001-03-19 2003-07-15 Icagen, Inc. Bisarylamines as potassium channel openers
EP1372654A4 (en) 2001-04-06 2007-10-03 Smithkline Beecham Corp QUINOLINE INHIBITORS OF HYAK1 AND HYAK3 KINASES
AU2003272552A1 (en) 2002-09-17 2004-04-08 Pharmacia Corporation Aromatic liver x-receptor modulators
JP4652816B2 (ja) 2002-12-23 2011-03-16 アイシーエージェン インコーポレイテッド カリウムチャネルモジュレータとしてのキナゾリノン
EP1449841A1 (en) 2003-02-19 2004-08-25 Bayer CropScience SA New fungicidal compounds
EP1680411A2 (en) 2003-10-08 2006-07-19 Vertex Pharmaceuticals Incorporated Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
EP1756043B1 (en) 2004-05-04 2009-07-01 RaQualia Pharma Inc Ortho substituted aryl or heteroaryl amide compounds
JP2008519814A (ja) 2004-11-12 2008-06-12 ガラパゴス・ナムローゼ・フェンノートシャップ プロテインキナーゼ酵素の活性部位と結合する窒素複素環式芳香族化合物
PL2298766T3 (pl) 2005-03-03 2014-09-30 H Lundbeck As Preparaty farmaceutyczne zawierające podstawione pochodne pirydyny
DE102005038947A1 (de) 2005-05-18 2006-11-30 Grünenthal GmbH Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
ATE432259T1 (de) 2005-07-20 2009-06-15 Lilly Co Eli Pyridinderivate als dipeptedyl-peptidase-hemmer
EP1922311A2 (en) 2005-09-09 2008-05-21 Brystol-Myers Squibb Company Acyclic ikur inhibitors
WO2007057447A1 (en) * 2005-11-18 2007-05-24 Neurosearch A/S Novel quinazoline derivatives and their medical use
ES2338278T3 (es) 2006-07-20 2010-05-05 Amgen Inc. Derivados de benzo(d)isoxazol como inhibidores de c-kit tirosina quinasa para el tratamiento de enfermedades asociadas con la sobreproduccion de histamina.
WO2008011110A2 (en) 2006-07-20 2008-01-24 Amgen Inc. Di-amino-substituted heterocyclic compounds and methods of use
WO2008012532A2 (en) 2006-07-27 2008-01-31 Astrazeneca Ab : pyridine-3-carboxamide compounds and their use for inhibiting 11-beta-hydroxysteroid dehydrogenase
DE102006049452A1 (de) 2006-10-17 2008-05-08 Grünenthal GmbH Substituierte Tetrahydropyrolopiperazin-Verbindungen und deren Verwendung in Arzneimitteln
US8563566B2 (en) 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
BRPI0814758A2 (pt) 2007-08-03 2015-03-03 Hoffmann La Roche Piridinacarboxamida e derivados de benzamida como ligantes taar1
US8299123B2 (en) 2007-10-19 2012-10-30 Boehringer Ingelheim International Gmbh CCR10 antagonists
BRPI1009428A2 (pt) 2009-03-10 2016-03-01 Gruenenthal Gmbh 3-aminoisoxazolopiridina substituída como moduladores de kcnq2/3
TW201038565A (en) 2009-03-12 2010-11-01 Gruenenthal Gmbh Substituted 2-mercapto-3-aminopyridines as KCNQ2/3 modulators
TWI475020B (zh) 2009-03-12 2015-03-01 The substituted nicotine amide as a KCNQ2 / 3 modifier
TWI461197B (zh) 2009-03-12 2014-11-21 2-mercaptoquinoline-3-carboxamide as a KCNQ2 / 3 modifier

Similar Documents

Publication Publication Date Title
JP2012520249A5 (enExample)
JP2012521966A5 (enExample)
Herring et al. Concussion (mild traumatic brain injury) and the team physician: a consensus statement--2011 update
JP2018513107A5 (enExample)
JP2012006970A5 (enExample)
JP2009510044A5 (enExample)
JP2009533356A5 (enExample)
MY167423A (en) Quinoline carboxamide and quinoline carbonitrile derivatives as mglur2-negative allosteric modulators,compositions,and their use
EA201891374A1 (ru) Замещенные 2-фенил-3-(пиперазинметил)имидазопиридины и их применение
JP2009504622A5 (enExample)
RU2018138183A (ru) Оксистеролы и способы их применения
JP2015535270A5 (enExample)
RU2013108258A (ru) Применение разагилина для лечения обонятельной дисфункции
JP2015512386A5 (enExample)
WO2008087461B1 (en) Use of kynurenic acid and derivatives thereof in the treatment of conditions of the gastrointestinal tract accompanied by hypermotility and inflammation or gout or multiple sclerosis
JP2013516475A5 (enExample)
Khasanov et al. Optimization of the diagnosis of ronchopathy in patients with diseases of ENT-organs
WO2017119456A1 (ja) せん妄の予防または治療剤
CL2014001046A1 (es) Proceso de preparacion de compuestos derivados de acilguanidinas y aciltioureas, utiles para el tratamiento de enfermedades de los pulmones y de las vias respiratorias; y compuestos intermediarios utilizados en dicho proceso.
WO2012038850A8 (en) Pyrimidones for treatment of potassium channel related diseases
Cai et al. Negative suction approach to remove living leeches from the nasal cavity
FR2974512B1 (fr) Composition anti-inflammatoire de l'intestin comprenant du maltitol
HRP20160832T1 (hr) Liječenje osteoporoze
JP2010195697A5 (enExample)
Han et al. A retrospective study of 54 cases with chronic otitis media prepared for staging tympanoplasty